Federal Register / Vol. 69, No. 246 / Thursday, December 23, 2004 / Notices 76949

identification or classification of such 

specimens. * * *’’

Authority: Section 122 of the Medicare, 

Medicaid, and SCHIP Benefits Improvement 

and Protection Act of 2000 (BIPA) (Pub. L. 

106–554).

(Catalog of Federal Domestic Assistance 

Program No. 93.779, Medical Assistance 

Program; No. 93.773, Medicare—Hospital 

Insurance Program; and No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program)

Dated: September 15, 2004. 

Mark B. McClellan, 

Administrator, Centers for Medicare & 

Medicaid Services.

[FR Doc. 04–27527 Filed 12–14–04; 8:45 am] 

BILLING CODE 4120–01–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Statement of Organization, Functions 

and Delegations of Authority 

This notice amends Part K of the 

Statement of Organization, Functions 

and Delegations of Authority of the 

Department of Health and Human 

Services (HHS), Administration for 

Children and Families (ACF), as 

follows: Chapter KA, Office of the 

Assistant Secretary for Children and 

Families (OAS) as last amended October 

16, 2001 (66 FR 52627) and Chapter KN, 

Office of Public Affairs (OPA) as last 

amended January 2, 1998 (63 FR 81–87). 

This notice announces the transfer of 

the Freedom of Information Act (FOIA) 

functions from the Office of the 

Executive Secretariat and places them in 

the Division of Public Information, 

Office of Public Affairs. 

These Chapters are amended as 

follows: 

I. Chapter KA, Office of the Assistant 

Secretary for Children and Families 

A. Delete KA.20 Functions, Paragraph 

C in its entirety and replace with the 

following: 

C. The Executive Secretariat (ExecSec) 

ensures that issues requiring the 

attention of the Assistant Secretary, 

Deputy Assistant Secretaries and/or 

executive staff are addressed on a timely 

and coordinated basis and facilitates 

decisions on matters requiring 

immediate action including White 

House, Congressional and Secretarial 

assignments. ExecSec serves as the ACF 

liaison with the HHS Executive 

Secretariat. It receives, assesses and 

controls incoming correspondence and 

assignments to the appropriate ACF 

component(s) for response and action 

and provides assistance and advice to 

ACF staff on the development of 

responses to correspondence. ExecSec 

provides assistance to ACF staff on the 

use of the controlled correspondence 

system. ExecSec coordinates and/or 

prepares congressional correspondence, 

tracks development of periodic reports 

and facilitates Departmental clearances. 

II. Chapter KN, Office of Public Affairs 

A. Delete KN.00. Mission in its 

entirety and replace with the following: 

KN.00 Mission. The Office of Public 

Affairs (OPA) develops, directs and 

coordinates public affairs and 

communications services for ACF. OPA 

serves as liaison with the Office of the 

Secretary, Office of Public Affairs in 

processing the Freedom of Information 

Act inquiries for ACF and coordinates 

hot line calls received by the Office of 

Inspector General and the Government 

Accountability Office relating to ACF 

operations and personnel. OPA provides 

leadership, direction and oversight in 

promoting ACF’s public affairs policies, 

programs and initiatives. OPA also 

provides printing and distribution 

services for ACF. 

B. Delete KN.20 Functions paragraph 

B, in its entirety and replace with the 

following: 

B. The Division of Public Information 

(the Division) develops and implements 

public affairs strategies to achieve ACF 

program objectives in coordination with 

other ACF components. The Division 

coordinates news media relations 

strategy; responds to all media inquiries 

concerning ACF programs and related 

issues; develops fact sheets, news 

releases, feature articles for magazines 

and other publications on ACF 

programs and initiatives; and manages 

preparation and clearance of speeches 

and official statements on ACF 

programs. The Division coordinates 

regional public affairs policies and 

public affairs activities pertaining to 

ACF programs and initiatives. The 

Division Director serves as liaison to the 

Office of the Secretary, Office of Public 

Affairs in processing the Freedom of 

Information Act inquiries and 

coordinates hot line calls received by 

the Office of Inspector General and the 

Government Accountability Office 

relating to ACF operations and 

personnel.

Dated: December 14, 2004. 

Wade F. Horn, 

Assistant Secretary for Children and Families.

[FR Doc. 04–28052 Filed 12–22–04; 8:45 am] 

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing

AGENCY: National Institutes of Health, 

Public Health Service, HHS.

ACTION: Notice.

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing.

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Non-Small Cell Lung Cancer Cell Line 

H3255

Herbert K. Oie et al. (NCI) 

DHHS Reference No. E–028–2005/0—

Research Tool 

Licensing Contact: Mojdeh Bahar; 301/

435–2950; baharm@mail.nih.gov.

This invention, the H3255 cell line, 

was initiated from malignant cells 

isolated from the pleural effusion from 

a non-smoker Caucasian female. The 

cultured tumor cells, identified as NonSmall Cell Lung Carcinoma Cells 

(NSCLC), were found to have a mutation 

within the EGFR gene that made them 

very sensitive to certain growth 

inhibiting drugs, such as gefitinib 

(iressa). Cell lines sensitive to growth 

inhibitors could be used in the 

treatment of cancer as potential 

chemotherapeutic agents. 

LRATlerin, Related Compounds and 

Methods of Use 

Denise P. Simmons (NCI) 

U.S. Provisional Application No. 60/

613,256 filed 27 Sep 2004 (DHHS 

Reference No. E–349–2004/0–US–01) 

Licensing Contact: Mojdeh Bahar; 301/

435–2950; baharm@mail.nih.gov.

The invention discloses combinations 

of anti-tumor agents and antiVerDate jul<14>2003 16:12 Dec 22, 2004 Jkt 205001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\23DEN1.SGM 23DEN1